Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Procter & Gamble Co., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Accounts payable	15,609)	15,227)	14,512)	14,495)	15,350)	15,364)	13,691)	14,234)	14,435)	14,598)	13,790)	14,153)	14,845)	14,882)	14,175)	14,154)	14,223)	13,720)	12,134)	12,027)	11,935)	12,071)	10,464)	10,781)	10,951)
Accrued and other liabilities	10,755)	11,318)	9,847)	9,878)	10,661)	11,072)	10,920)	11,100)	10,912)	10,929)	10,523)	10,293)	10,056)	9,554)	10,324)	10,542)	10,377)	10,523)	11,109)	11,131)	10,366)	9,722)	9,731)	10,230)	9,950)
Debt due within one year	11,631)	9,513)	9,889)	9,424)	10,409)	7,191)	7,729)	10,616)	11,811)	10,229)	13,717)	14,300)	11,717)	8,645)	9,902)	13,331)	11,989)	8,889)	8,773)	8,586)	7,707)	11,183)	12,701)	9,153)	9,352)
Current liabilities	37,995)	36,058)	34,248)	33,797)	36,420)	33,627)	32,340)	35,950)	37,158)	35,756)	38,030)	38,746)	36,618)	33,081)	34,401)	38,027)	36,589)	33,132)	32,016)	31,744)	30,008)	32,976)	32,896)	30,164)	30,253)
Long-term debt, excluding due within one year	24,315)	24,995)	24,252)	25,263)	25,744)	25,269)	24,253)	23,096)	24,069)	24,378)	22,874)	20,582)	21,286)	22,848)	23,767)	22,322)	20,558)	23,099)	21,053)	22,514)	23,948)	23,537)	23,310)	18,985)	20,161)
Deferred income taxes	5,893)	5,774)	6,481)	6,725)	6,420)	6,516)	6,284)	6,219)	6,814)	6,478)	6,422)	6,462)	6,986)	6,809)	6,543)	6,506)	6,323)	6,153)	5,977)	6,073)	6,294)	6,199)	6,309)	6,242)	6,325)
Other noncurrent liabilities	5,845)	6,119)	5,458)	5,410)	5,757)	6,399)	6,387)	6,615)	6,476)	7,152)	7,104)	7,200)	7,058)	7,616)	9,760)	9,668)	9,791)	10,269)	10,813)	11,241)	11,073)	11,110)	10,104)	10,424)	10,335)
Noncurrent liabilities	36,053)	36,888)	36,191)	37,398)	37,921)	38,184)	36,924)	35,930)	37,359)	38,008)	36,400)	34,244)	35,330)	37,273)	40,070)	38,496)	36,672)	39,521)	37,843)	39,828)	41,315)	40,846)	39,723)	35,651)	36,821)
Total liabilities	74,048)	72,946)	70,439)	71,195)	74,341)	71,811)	69,264)	71,880)	74,517)	73,764)	74,430)	72,990)	71,948)	70,354)	74,471)	76,523)	73,261)	72,653)	69,859)	71,572)	71,323)	73,822)	72,619)	65,815)	67,074)
Preferred stock	770)	777)	781)	788)	791)	798)	801)	809)	812)	819)	822)	831)	834)	843)	846)	856)	859)	870)	873)	885)	888)	897)	900)	911)	915)
Common stock	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)	4,009)
Additional paid-in capital	68,917)	68,770)	68,615)	68,283)	68,102)	67,684)	67,395)	66,935)	66,822)	66,556)	66,316)	66,145)	65,955)	65,795)	65,614)	65,432)	65,148)	64,848)	64,682)	64,672)	64,467)	64,194)	63,976)	64,019)	63,949)
Reserve for ESOP debt retirement	(637)	(672)	(672)	(707)	(707)	(737)	(737)	(782)	(782)	(821)	(821)	(870)	(870)	(916)	(916)	(965)	(964)	(1,006)	(1,006)	(1,072)	(1,046)	(1,080)	(1,080)	(1,112)	(1,112)
Accumulated other comprehensive loss	(12,156)	(12,143)	(11,307)	(11,637)	(10,893)	(11,900)	(12,370)	(12,167)	(12,583)	(12,220)	(12,266)	(12,506)	(12,811)	(12,189)	(13,448)	(13,564)	(14,062)	(13,744)	(15,489)	(15,091)	(15,881)	(16,165)	(15,916)	(14,942)	(15,298)
Treasury stock	(139,845)	(138,702)	(138,073)	(137,112)	(134,823)	(133,378)	(132,172)	(131,886)	(131,028)	(129,736)	(130,002)	(129,012)	(127,205)	(123,382)	(122,272)	(121,543)	(117,240)	(114,973)	(112,147)	(109,583)	(106,794)	(105,573)	(105,823)	(105,761)	(102,510)
Retained earnings	132,212)	129,973)	128,919)	127,544)	125,361)	123,811)	123,132)	121,617)	120,443)	118,170)	117,082)	115,858)	114,163)	112,429)	111,645)	110,393)	108,361)	106,374)	105,674)	104,361)	102,539)	100,239)	99,474)	98,414)	96,625)
Shareholders’ equity attributable to Procter & Gamble	53,270)	52,012)	52,272)	51,168)	51,840)	50,287)	50,058)	48,535)	47,693)	46,777)	45,140)	44,455)	44,075)	46,589)	45,478)	44,618)	46,111)	46,378)	46,596)	48,181)	48,182)	46,521)	45,540)	45,538)	46,578)
Noncontrolling interest	281)	272)	273)	275)	301)	272)	275)	294)	321)	288)	281)	270)	259)	265)	268)	275)	297)	276)	323)	359)	394)	357)	401)	370)	406)
Total shareholders’ equity	53,551)	52,284)	52,545)	51,443)	52,141)	50,559)	50,333)	48,829)	48,014)	47,065)	45,421)	44,725)	44,334)	46,854)	45,746)	44,893)	46,408)	46,654)	46,919)	48,540)	48,576)	46,878)	45,941)	45,908)	46,984)
Total liabilities and shareholders’ equity	127,599)	125,230)	122,984)	122,638)	126,482)	122,370)	119,597)	120,709)	122,531)	120,829)	119,851)	117,715)	116,282)	117,208)	120,217)	121,416)	119,669)	119,307)	116,778)	120,112)	119,899)	120,700)	118,560)	111,723)	114,058)

Accounts Payable: Accounts payable generally increased from 10,951 million in September 2019 to 15,609 million by September 2025, showing a gradual upward trend with some fluctuations along the periods. The highest observed values occur in the later quarters, indicating increased obligations to suppliers or vendors.
Accrued and Other Liabilities: This liability category shows moderate volatility without a distinct directional trend, fluctuating between approximately 9,550 million and 11,300 million. Peaks occur around late 2020 and mid-2023, with slight decreases towards the end of the timeline.
Debt Due Within One Year: Short-term debt exhibited significant variability, rising sharply to a high near 14,300 million in late 2022 and then fluctuating downward to roughly 9,500 million by late 2025. The pattern suggests periods of refinancing or changing short-term borrowing strategies.
Current Liabilities: Current liabilities increased overall from around 30,253 million in late 2019 to peaks exceeding 38,700 million in late 2022, followed by a mild decline and subsequent fluctuations near 38,000 million. This reflects a growth in short-term obligations and working capital needs over the period.
Long-Term Debt (Excluding Due Within One Year): Long-term debt shows oscillations, decreasing from 20,161 million in late 2019 to lows near 20,500 million in late 2021, then generally increasing and peaking at over 25,700 million in late 2024 before a slight decline. This suggests active debt management and perhaps refinancing activities over time.
Deferred Income Taxes: This liability stays relatively stable around the 6,200 to 7,000 million mark, with moderate fluctuations. No notable upward or downward long-term trend is apparent.
Other Noncurrent Liabilities: Other noncurrent liabilities decreased steadily from over 10,300 million in late 2019 to below 6,000 million by late 2025, indicating a reduction in miscellaneous or less defined long-term obligations.
Noncurrent Liabilities: Total noncurrent liabilities increased initially, reaching a high near 41,300 million in late 2020, then exhibited a downward trend to about 36,000 million by late 2025, reflecting the reduction in other noncurrent liabilities and variability in long-term debt balances.
Total Liabilities: Total liabilities peaked around 76,500 million in late 2021, followed by decreases and some recovery periods. Overall, liabilities show growth from 67,074 million in late 2019 to approximately 74,000 million by late 2025, reflecting increased obligations but with periods of consolidation.
Preferred Stock: Preferred stock decreased slightly over time from 915 million to 770 million, representing a gradual buyback, retirement, or conversion of preferred shares.
Common Stock: Common stock was steady at 4,009 million throughout the entire period, indicating no changes in the par value or common shares outstanding.
Additional Paid-in Capital: Additional paid-in capital steadily increased from about 63,949 million to nearly 68,917 million, indicating ongoing capital contributions or equity issuances.
Reserve for ESOP Debt Retirement: This reserve decreased steadily from approximately -1,112 million to -637 million, indicating reduction in the obligations or funds set aside for employee stock ownership plan debt.
Accumulated Other Comprehensive Loss: The accumulated other comprehensive loss shows moderate fluctuations in negative territory, ranging approximately from -15,300 million to -10,800 million early on, improving slightly around 2024, but ending near -12,100 million, indicating persistent unrealized losses or other comprehensive income impacts.
Treasury Stock: Treasury stock steadily increased in absolute value (negative) from -102,510 million to nearly -139,845 million, indicating consistent share repurchases and reductions in outstanding equity.
Retained Earnings: Retained earnings exhibited continuous growth from 96,625 million to 132,212 million, reflecting accumulated earnings retained by the company and indicating ongoing profitability and reinvestment.
Shareholders’ Equity Attributable to the Company: Shareholders’ equity attributable to the company experienced some volatility, with a dip in late 2021 to around 44,600 million, but overall an upward movement to approximately 53,270 million by late 2025, suggesting strengthening equity base.
Noncontrolling Interest: Noncontrolling interest remained low and relatively stable, fluctuating modestly around the 270 to 400 million mark, indicating minor ownership stakes held by third parties.
Total Shareholders’ Equity: Total shareholders' equity mirrored the company’s own equity trends, showing volatility but an overall increase from about 46,984 million to 53,551 million, signaling growing total equity capital.
Total Liabilities and Shareholders’ Equity: The sum of total liabilities and shareholders’ equity increased from approximately 114,058 million to 127,599 million over the period, illustrating growth in the company's balance sheet size and overall financial position.

Download chart

Procter & Gamble Co. (NYSE:PG)

Balance Sheet: Liabilities and Stockholders’ Equity Quarterly Data

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data